Analyst coverage

About us

Zealand Pharma is an international biotechnology company headquartered in Denmark. We are focused on the discovery, design, and development of innovative peptide-based medicines for people who need them.

Disease areas

Zealand Pharma is focused on disease areas where we believe peptide therapies can make a difference for people living with unmet medical needs.

Pipeline

At Zealand Pharma, our research and development is directed at generating a pipeline of novel and differentiated peptide candidates.

Investors

Zealand Pharma is committed to creating value for our society and our shareholders through life-changing peptide therapeutics for people who need them.

News & media

Zealand Pharma provides news through company announcements and press releases.

Careers

At Zealand Pharma we pride ourselves on the way we work together as one team fostering a strong and engaging company culture founded on collaboration, courage, empowerment, and trust.

Contact

Zealand Pharma is followed by these financial institutions and analysts

Bank of America - Charlie Haywood
Berenberg - Kerry Holford
BTIG - Julian Harrison
Cantor Fitzgerald - Prakhar Agrawal
Carnegie - Jesper Ilsøe
Deutsche Bank AG - Emmanuel Papadakis
DNB - Rune Majlund Dahl
Goldman Sachs & Co. - Rajan Sharma
Jefferies - Lucy Codrington
J.P. Morgan - James Gordon
KBC Securities - Jacob Mekhael
Nordea - Michael Novod
SEB - Thomas Bowers
Van Lanschot Kempen - Suzanne van Voorthuizen
William Blair - Andy Hsieh

You are about to leave Zealand Pharma's website

The link below goes to a website not owned by Zealand Pharma:

Zealand Pharma does not endorse the content of any such third-party website